Evidence map›Paper›PMID 30670531›Full record

ArticleBMJ open2019

Vitamin B

Shamon Ahmed, Chrysi Bogiatzi, Daniel G Hackam, Angela C Rutledge, Luciano A Sposato, Alexander Khaw, Jennifer Mandzia, Mahmoud Reza Azarpazhoo, Vladimir Hachinski, J David Spence

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06190314 (SERUM VITAMIN B12 LEVELS IN PATIENTS WITH HEMORRHAGIC VS ISCHEMIC CEREBROVASCULAR EVENT.), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06190314 unknown statusnot on this mapstarted 2023, after this paper: background citation

Serum vitamin b12 levels in patients with hemorrhagic vs ischemic cerebrovascular event.

Typeobservational_patient_registrySponsorHospital General de MexicaliRan2023 to 2024Enrolled100ConditionsCerebrovascular Event, Vitamin b12, Hemorrhagic Stroke, Ischemic StrokeArmsMeasure serum vitamin b12 levels
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. The Multitarget Action of Vitamins in the Ischemic Stroke.Current topics in medicinal chemistry · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Management of asymptomatic carotid stenosis.Annals of translational medicine · 2020
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shamon AhmedUniversity of British Columbia Medical School, Vancouver, British Columbia, Canada.
Chrysi Bogiatzi
Daniel G HackamDivision of Clinical Pharmacology, Department of Medicine, Western University, London, Ontario, Canada.
Angela C RutledgeDepartment of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
Luciano A SposatoUniversity Hospital, London, Ontario, Canada.
Alexander KhawUniversity Hospital, London, Ontario, Canada.
Jennifer MandziaUniversity Hospital, London, Ontario, Canada.
Mahmoud Reza AzarpazhooUniversity Hospital, London, Ontario, Canada.
Vladimir HachinskiUniversity Hospital, London, Ontario, Canada.
J David SpenceDivision of Clinical Pharmacology, Department of Medicine, Western University, London, Ontario, Canada.ORCID 0000-0001-7478-1098
Western University · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe sought to assess the current magnitude of the opportunity for secondary stroke prevention with B vitamins.

designA cohort study.

settingThe Urgent TIA (Transient Ischaemic Attack) Clinic at an academic medical centre.

main outcome measuresWe assessed the prevalence of biochemical vitamin B

resultsData were available in 4055 patients. B

conclusionsDespite a decline in our referral area since 2009, B

Indexed as

Academic Medical CentersAgedAged, 80 and overCohort StudiesDietary SupplementsFemaleHomocysteineHumansHyperhomocysteinemiaIschemic Attack, TransientMaleMiddle AgedOntarioSecondary PreventionStrokeVitamin B 12HomocysteineVitamin B 12B12homocysteinestroke

Identifiers

PMID30670531
PMCPMC6347886
OpenAlexW2912579484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.